这是一篇来自已证抗体库的有关人类 二肽基肽酶4 (DPP4) 的综述,是根据25篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合二肽基肽酶4 抗体。
二肽基肽酶4 同义词: ADABP; ADCP2; CD26; DPPIV; TP103

BioLegend
小鼠 单克隆(BA5b)
  • mass cytometry; 人类; 图 4a
BioLegend二肽基肽酶4抗体(Biolegend, 302702)被用于被用于mass cytometry在人类样本上 (图 4a). Cell Rep (2022) ncbi
小鼠 单克隆(BA5b)
  • 流式细胞仪; 人类; 图 7a
BioLegend二肽基肽酶4抗体(Biolegend, BA5b)被用于被用于流式细胞仪在人类样本上 (图 7a). J Clin Invest (2021) ncbi
小鼠 单克隆(BA5b)
  • 流式细胞仪; 小鼠; 1:100; 图 4a
BioLegend二肽基肽酶4抗体(Biolegend, 302704)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 4a). Science (2019) ncbi
小鼠 单克隆(BA5b)
  • 流式细胞仪; 人类; 图 2b
BioLegend二肽基肽酶4抗体(BioLegend, BA5b)被用于被用于流式细胞仪在人类样本上 (图 2b). Sci Rep (2017) ncbi
小鼠 单克隆(BA5b)
  • 流式细胞仪; 人类; 图 s14b
BioLegend二肽基肽酶4抗体(BioLegend, BA5b)被用于被用于流式细胞仪在人类样本上 (图 s14b). Science (2017) ncbi
小鼠 单克隆(BA5b)
  • 流式细胞仪; 人类; 图 st12
BioLegend二肽基肽酶4抗体(Biolegend, BA5b)被用于被用于流式细胞仪在人类样本上 (图 st12). Science (2017) ncbi
小鼠 单克隆(BA5b)
  • 流式细胞仪; 人类; 图 6b
BioLegend二肽基肽酶4抗体(BioLegend, 302705)被用于被用于流式细胞仪在人类样本上 (图 6b). Cell Stem Cell (2017) ncbi
小鼠 单克隆(BA5b)
  • 流式细胞仪; 人类; 图 3g
BioLegend二肽基肽酶4抗体(BioLegend, BA5b)被用于被用于流式细胞仪在人类样本上 (图 3g). Sci Rep (2016) ncbi
赛默飞世尔
domestic rabbit 重组(JM11-42)
  • 免疫印迹; 人类; 1:1000; 图 2c
赛默飞世尔二肽基肽酶4抗体(Thermo Fisher, MA532643)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2c). Clin Transl Med (2022) ncbi
小鼠 单克隆(2A6)
赛默飞世尔二肽基肽酶4抗体(eBiosciences, 2A6)被用于. J Virol (2017) ncbi
小鼠 单克隆(BA5b)
  • 流式细胞仪; 人类; 表 2
赛默飞世尔二肽基肽酶4抗体(Invitrogen, BA5b)被用于被用于流式细胞仪在人类样本上 (表 2). Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(M-A261)
  • 流式细胞仪; 人类
赛默飞世尔二肽基肽酶4抗体(eBioscience, M-A261)被用于被用于流式细胞仪在人类样本上. Clin Exp Immunol (2014) ncbi
安迪生物R&D
domestic goat 多克隆
  • 免疫组化基因敲除验证; 人类; 1:200; 图 3d
安迪生物R&D二肽基肽酶4抗体(R&D Systems, AF1180)被用于被用于免疫组化基因敲除验证在人类样本上浓度为1:200 (图 3d). Nat Commun (2021) ncbi
domestic goat 多克隆
  • 其他; 人类; 1:10; 图 s4f, s4h
安迪生物R&D二肽基肽酶4抗体(R&D, AF1180)被用于被用于其他在人类样本上浓度为1:10 (图 s4f, s4h). J Clin Med (2021) ncbi
美天旎
小鼠 单克隆(FR10-11G9)
  • 流式细胞仪; 人类; 1:11; 图 2s2b
美天旎二肽基肽酶4抗体(Miltenyi Biotech, FR10-11G9)被用于被用于流式细胞仪在人类样本上浓度为1:11 (图 2s2b). elife (2019) ncbi
北京傲锐东源
小鼠 单克隆(OTI11D7)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 3
北京傲锐东源二肽基肽酶4抗体(Origene, TA500733)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 3). Am J Pathol (2016) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 其他; 人类; 图 4c
艾博抗(上海)贸易有限公司二肽基肽酶4抗体(Abcam, ab28340)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(M-A261)
  • 免疫细胞化学; 人类; 图 2
伯乐(Bio-Rad)公司二肽基肽酶4抗体(AbD Serotec, M-A261)被用于被用于免疫细胞化学在人类样本上 (图 2). J Virol (2017) ncbi
圣克鲁斯生物技术
小鼠 单克隆(BA5)
  • proximity ligation assay; 人类; 1:50-1:100; 图 6
圣克鲁斯生物技术二肽基肽酶4抗体(Santa Cruz, sc-19607)被用于被用于proximity ligation assay在人类样本上浓度为1:50-1:100 (图 6). elife (2016) ncbi
碧迪BD
小鼠 单克隆(M-A261)
  • 流式细胞仪; 人类; 表 3
碧迪BD二肽基肽酶4抗体(BD Pharmingen, M-A261)被用于被用于流式细胞仪在人类样本上 (表 3). Brain Behav (2016) ncbi
小鼠 单克隆(M-A261)
  • 其他; 人类; 500 ug/ml; 图 1
碧迪BD二肽基肽酶4抗体(Becton Dickinson, 555435)被用于被用于其他在人类样本上浓度为500 ug/ml (图 1). J Extracell Vesicles (2016) ncbi
小鼠 单克隆(M-A261)
  • 流式细胞仪; 人类; 图 st1
碧迪BD二肽基肽酶4抗体(BD, 555437)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(L272)
  • 流式细胞仪; 人类; 图 3c
碧迪BD二肽基肽酶4抗体(BD Pharmingen, L272)被用于被用于流式细胞仪在人类样本上 (图 3c). Retrovirology (2015) ncbi
小鼠 单克隆(M-A261)
  • 流式细胞仪; 人类; 图 2b
碧迪BD二肽基肽酶4抗体(BD Biosciences, M-A261)被用于被用于流式细胞仪在人类样本上 (图 2b). J Immunol (2015) ncbi
小鼠 单克隆(M-A261)
  • 流式细胞仪; 人类; 图 3
碧迪BD二肽基肽酶4抗体(BD Biosciences, M-A261)被用于被用于流式细胞仪在人类样本上 (图 3). J Autoimmun (2015) ncbi
Developmental Studies Hybridoma Bank
小鼠 单克隆(HBB3/775/42)
  • 免疫组化-冰冻切片; 人类; 1:100; 图 1d
Developmental Studies Hybridoma Bank二肽基肽酶4抗体(DSHB, HBB3/775/42)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:100 (图 1d). J Clin Med (2021) ncbi
文章列表
  1. Baik J, Park H, Kataru R, Savetsky I, Ly C, Shin J, et al. TGF-β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation. Clin Transl Med. 2022;12:e758 pubmed 出版商
  2. van der Heide V, Jangra S, Cohen P, Rathnasinghe R, Aslam S, Aydillo T, et al. Limited extent and consequences of pancreatic SARS-CoV-2 infection. Cell Rep. 2022;38:110508 pubmed 出版商
  3. Beumer J, Geurts M, Lamers M, Puschhof J, Zhang J, van der Vaart J, et al. A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses. Nat Commun. 2021;12:5498 pubmed 出版商
  4. Hess M, Krainer I, Filipek P, Witting B, Gutleben K, Vietor I, et al. Advanced Microscopy for Liver and Gut Ultrastructural Pathology in Patients with MVID and PFIC Caused by MYO5B Mutations. J Clin Med. 2021;10: pubmed 出版商
  5. Harro C, Perez Sanz J, Costich T, Payne K, Anadon C, Chaurio R, et al. Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice. J Clin Invest. 2021;131: pubmed 出版商
  6. Katsuda T, Matsuzaki J, Yamaguchi T, Yamada Y, Prieto Vila M, Hosaka K, et al. Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes. elife. 2019;8: pubmed 出版商
  7. MERRICK D, Sakers A, Irgebay Z, Okada C, Calvert C, Morley M, et al. Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. Science. 2019;364: pubmed 出版商
  8. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  9. Belouzard S, Danneels A, Fénéant L, Séron K, Rouille Y, Dubuisson J. Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes. J Virol. 2017;91: pubmed 出版商
  10. Allan D, Cerdeira A, Ranjan A, Kirkham C, Aguilar O, Tanaka M, et al. Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. Sci Rep. 2017;7:3501 pubmed 出版商
  11. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed 出版商
  12. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed 出版商
  13. McCauley K, Hawkins F, Serra M, Thomas D, JACOB A, Kotton D. Efficient Derivation of Functional Human Airway Epithelium from Pluripotent Stem Cells via Temporal Regulation of Wnt Signaling. Cell Stem Cell. 2017;20:844-857.e6 pubmed 出版商
  14. Coleman C, Sisk J, Halasz G, Zhong J, Beck S, Matthews K, et al. CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome. J Virol. 2017;91: pubmed 出版商
  15. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  16. Justa Schuch D, Silva Garcia M, Pilla E, Engelke M, Kilisch M, Lenz C, et al. DPP9 is a novel component of the N-end rule pathway targeting the tyrosine kinase Syk. elife. 2016;5: pubmed 出版商
  17. Jiang J, Chen X, An H, Yang B, Zhang F, Cheng X. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep. 2016;6:32320 pubmed 出版商
  18. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed 出版商
  19. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  20. Meyerholz D, Lambertz A, McCray P. Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome. Am J Pathol. 2016;186:78-86 pubmed 出版商
  21. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed 出版商
  22. Ohnuma K, Hatano R, Aune T, Otsuka H, Iwata S, Dang N, et al. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol. 2015;194:3697-712 pubmed 出版商
  23. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed 出版商
  24. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  25. Schuler P, Saze Z, Hong C, Muller L, Gillespie D, Cheng D, et al. Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells. Clin Exp Immunol. 2014;177:531-43 pubmed 出版商